Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase EARLY_PHASE1 3Phase 2 2Phase 4 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Gastrointestinal 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms 2Dyspareunia 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Fish Oils × Breast × Clear all
NCT01869764 2019-10-30

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Wake Forest University Health Sciences

Phase 2 Completed
57 enrolled 8 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Male

NCT02150525 2018-08-09

Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase 2 Completed
52 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Dyspareunia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡